# PediCARE Health Equity Intervention in High-Risk Neuroblastoma

> **NCT06335745** · NA · WITHDRAWN · sponsor: **Dana-Farber Cancer Institute**

## Conditions studied

- Neuroblastoma
- High-risk Neuroblastoma
- Pediatric Cancer
- Disparities
- Financial Stress
- Poverty

## Interventions

- **BEHAVIORAL:** PediCARE Intervention

## Key facts

- **NCT ID:** NCT06335745
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-09
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study halted prematurely, prior to enrollment of first participant
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06335745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06335745, "PediCARE Health Equity Intervention in High-Risk Neuroblastoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06335745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*